Navigation Links
Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
Date:11/4/2010

BOSTON, Nov. 4, 2010 /PRNewswire-FirstCall/ -- PAREXEL Consulting, a business unit of PAREXEL International (Nasdaq: PRXL) and a leading global consultancy serving the biopharmaceutical and medical device industries, today announced that Edwin Rivera-Martinez, B.S., M.B.A., former Chief of the U.S. Food and Drug Administration’s (FDA) International Compliance Branch, has been appointed as a Technical Vice President to its Strategic Compliance Services team, reporting directly to the Practice Lead.  This appointment further expands the Company’s global team of regulatory and compliance experts, which supports clients in navigating the increasingly complex regulatory environment and institutes proactive strategic compliance practices to help guide the success of their products.

Mr. Rivera-Martinez served for over 33 years at the FDA, including most recently as Chief of the FDA’s International Compliance Branch, within the Division of Manufacturing and Product Quality (DMPQ) in the Office of Compliance, Center for Drug Evaluation and Research (CDER), which oversees human drug and active pharmaceutical ingredients (API) inspections conducted internationally by the FDA.  From December 2002 to July 2009, he served as Chief of the Manufacturing Assessment and Preapproval Compliance Branch in DMPQ, where he directed the Agency’s human drug preapproval inspection program.  In that role, he assured the validity of data in applications and Current Good Manufacturing Practice (CGMP) compliance of both domestic and foreign manufacturing establishments referenced in new drug applications (NDAs) and abbreviated new drug applications (ANDAs) and supplements as well as biologics license
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6

Related biology technology :

1. Former Speaker of the House Newt Gingrich Featured Wednesday
2. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
3. Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off
4. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
5. Former Telomolecular CEO Clarifies SEC Settlement
6. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
7. Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
8. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
9. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
10. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
11. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 21, 2013 PathoGenetix, Inc., a commercial-stage ... typing, announced today that it has successfully identified and ... strains obtained from the Centers for Disease Control and ... technology. The findings are detailed in a poster ... Society for Microbiology in Denver on Monday. , The ...
(Date:5/21/2013)... May 21, 2013 Clinovo's new ... 8-week training program starting on June 11th, 2013. The ... trial professionals reach the next step in their professional ... in Palo Alto, and streamed online. , Taught by ... papers, Clinovo's new “CDISC Standards: Theory and Application” class ...
(Date:5/20/2013)... Grace Century , an international ... science and health related private equity projects, has announced ... Project Team. Dergham's expertise in finance and international law ... Grace Century as it continues to look at more ... holds both an under graduate degree from the University ...
(Date:5/20/2013)... May 20, 2013  MiMedx Group, Inc. (NASDAQ: ... of patent protected regenerative biomaterials and bioimplants processed from ... a revolving line of credit with Bank of America.  ... by the Company,s accounts receivable and inventory, allows MiMedx ... 2014.  The facility will be used for general corporate ...
Breaking Biology Technology:New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 2New Genotyping System Identifies Pathogenic E. coli Outbreak Strains 3Clinovo Launches TechTrainings on CDISC Standards 2Dalia Dergham Joins Grace Century FZ LLC International Project Team 2
... , , , PRINCETON, ... Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Officer, will present at the Rodman & Renshaw 11th Annual ... at 4:55 PM on Thursday, September 10, 2009 in the ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... , , - Rodman & Renshaw 11th ... September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon, ... Hotel in New York City., - Thomas ...
... 2 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Robert W. Baird & Co. 2009 Health Care Conference ... 2009 Health Care Conference in New York, New York, on September 9, 2009 ... Thomas Weisel Partners Healthcare Conference , Subsequently, Onyx will ...
Cached Biology Technology:DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 2DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 3DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 4OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 2Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences 2
(Date:5/21/2013)... infections occur in the body, stem cells in ... and differentiating into mature immune cells that can ... can deplete these cell populations, potentially leading to ... cancer. Now, a team of researchers led by ... has found that, in mouse models, the molecule ...
(Date:5/21/2013)... and health stores, phosphatidylserine is a natural food ... to improve cognition and slow memory loss, it,s ... impairment. Now a team headed by Prof. Gil ... University,s Department of Human Molecular Genetics ... functioning of genes involved in degenerative brain disorders, ...
(Date:5/21/2013)... of biomass experts , Where? Copenhagen, ... 03-07 June 2013 , Why? ... assessment, market and policy developments, manufacturing and installation, drawing ... benefiting from its 2013 edition from a record of ... countries, more than 240 plenary and oral presentations, more ...
Breaking Biology News(10 mins):Keeping stem cells strong 2Common food supplement fights degenerative brain disorders 221st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4
... the International Osteoporosis Foundation (IOF) in its 2009 publication, ... more than 50% of all osteoporotic fractures will occur ... there is a growing need for advanced clinical training ... epidemiology and specificities of osteoporosis and related bone disorders ...
... research could eventually lead to new approaches for controlling ... which are caused by trypanosomes carried by the bloodsucking ... reproduction evolved very early and is now ubiquitous in ... living organisms except bacteria). However, real evidence is ...
... of mucus associated with chronic bronchitis, according to a ... indicates cigarette smoke suppresses a protein that causes the ... bronchitis patients. The findings were published online ahead ... American Journal of Respiratory and Critical Care Medicine ...
Cached Biology News:Shining a light on trypanosome reproduction 2Cigarette smoking increases production of mucus in patients with bronchitis 2Cigarette smoking increases production of mucus in patients with bronchitis 3
... We deliversoluble protein or No Charge ... the best soluble protein results , 24 ... submitted , Powerful results on your most ... Optimization Service (SOS) uses proprietary tools and ...
... for proteomic scale kinase profiling, quantitative ... drug discovery research built on the ... synthesis platform. These microarrays are available ... Kinase Substrate - Peptide Microarray Service. ...
... immunological studies, vaccine development, and biosensor ... powerful Paraflo microfluidic on-chip synthesis platform. ... of our comprehensive Epitope Peptide Microarray ... Probe content is completely customer ...
... Introducing our Regulatory Edition of Molecular ... imaging systems for life science research and ... supports compliance with U.S. Food and Drug ... Part 11 Electronic Records; Electronic Signatures [21 ...
Biology Products: